75 results on '"Osteosarcoma -- Drug therapy"'
Search Results
2. New Findings from First People's Hospital in the Area of Osteosarcomas Reported [Construction of 5-fluorouracil Loaded Polydopamine Tailored Zeolite Imidazole Framework (Zif-8) As Potential Treatment for Osteosarcoma Cancer]
3. Researchers from Warsaw University of Life Sciences Report Findings in Liposomes (Peg-liposomal Doxorubicin As a Potential Agent for Canine Metastatic Osteosarcoma - In Vitro and Ex Ovo Studies)
4. New Findings from Sichuan University in the Area of Osteosarcomas Described (Thiram, an Inhibitor of 11 Beta-hydroxysteroid Dehydrogenase Type 2, Enhances the Inhibitory Effects of Hydrocortisone In the Treatment of Osteosarcoma Through ...)
5. Reports from Shahid Sadoughi University of Medical Sciences Add New Data to Research in Liposomes (A new approach to the development and assessment of doxorubicin-loaded nanoliposomes for the treatment of osteosarcoma in 2D and 3D cell culture ...)
6. Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
7. New Osteosarcomas Study Findings Have Been Published by Researchers at Second Affiliated Hospital of Harbin Medical University (Exosomes and osteosarcoma drug resistance)
8. New Osteosarcomas Study Findings Have Been Published by Researchers at Second Affiliated Hospital of Naval Medical University (BARX1 promotes osteosarcoma cell proliferation and invasion by regulating HSPA6 expression)
9. Researcher from Army Medical University Provides Details of New Studies and Findings in the Area of Osteosarcomas (Sustained and Targeted Delivery of Self-Assembled Doxorubicin Nonapeptides Using pH-Responsive Hydrogels for Osteosarcoma ...)
10. Department of Anesthesiology Researchers Add New Findings in the Area of Osteosarcomas (Propofol Regulates ER Stress to Inhibit Tumour Growth and Sensitize Osteosarcoma to Doxorubicin)
11. New Findings Reported from China-Japan Union Hospital of Jilin University Describe Advances in siRNA-Based Therapy (Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA)
12. Reports Outline Tissue Engineering Study Results from Beijing Institute of Technology (Developing a Versatile Multiscale Therapeutic Platform for Osteosarcoma Synergistic Photothermo-chemotherapy With Effective Osteogenicity and Antibacterial ...)
13. Reports Summarize Osteosarcomas Study Results from Sun Yat-sen University (Igf2bp1-regulated Expression of Err Alpha Is Involved In Metabolic Reprogramming of Chemotherapy Resistant Osteosarcoma Cells)
14. Reports from Alma Mater Studiorum - University of Bologna Add New Study Findings to Research in Cancer Research (A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma ...)
15. New Cancer Research Findings from Colorado State University Outlined (Losartan Blocks Osteosarcoma-elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit In Canine Metastatic ...)
16. Duke University Medical Center Researchers Advance Knowledge in Osteosarcomas (A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma)
17. A cross-species drug discovery pipeline to identify and validate new treatments for osteosarcoma
18. Innova Therapeutics receives US FDA Rare Pediatric Disease Designation for IVT-8086 to treat osteosarcoma
19. Study Results from New York Institute of Technology Broaden Understanding of Tissue Engineering (The Use of Hydrogels for the Treatment of Bone Osteosarcoma via Localized Drug-Delivery and Tissue Regeneration: A Narrative Review)
20. Studies from Houston Methodist Research Institute Provide New Data on Osteosarcomas (Tyrosine Kinase Inhibitor-loaded Biomimetic Nanoparticles As a Treatment for Osteosarcoma) (Tyrosine Kinase Inhibitor-loaded Biomimetic Nanoparticles As a ...)
21. Studies from Huazhong University of Science and Technology in the Area of Osteosarcomas Reported (Recent Advances of Drug Delivery Nanocarriers In Osteosarcoma Treatment)
22. Medpactos Vactosertib wins FDA orphan drug status for osteosarcoma
23. Bone Cancer Drugs Market to grow by USD 996.69 Million| Strong prevalence of osteosarcoma in younger patients will be one of the key drivers| Technavio
24. Bone Cancer Drugs Market to grow by USD 996.69 Million| Strong prevalence of osteosarcoma in younger patients will be one of the key drivers| Technavio
25. QSAM Biosciences Receives Orphan Drug Designation from FDA for CycloSam in the Treatment of Osteosarcoma
26. QSAM Biosciences Receives Orphan Drug Designation from FDA for CycloSam(R) in the Treatment of Osteosarcoma
27. Reports from Institute for Cancer Research and Treatment (IRCCS) Highlight Recent Findings in Osteosarcomas (Therapeutic potential of nvp-bkm120 in human osteosarcomas cells)
28. Investigators at Institute for Cancer Research and Treatment (IRCCS) Describe Findings in Osteosarcomas (Relevance of 3d culture systems to study osteosarcoma environment)
29. Findings from Institute for Cancer Research and Treatment (IRCCS) Broaden Understanding of Osteosarcomas [Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within ...]
30. Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients
31. Innova Therapeutics receives Rare Pediatric Disease Designation from FDA for IVT-8086 for Osteosarcoma
32. Innova Therapeutics Receives Rare Pediatric Disease Designation from the Food and Drug Administration (FDA) for IVT-8086 for the Treatment of Osteosarcoma
33. Researchers at Shanghai Jiao-Tong University Target Osteosarcomas (Antitumor effect of focal adhesion kinase inhibitor PF562271 against human osteosarcoma invitro and invivo)
34. Data from Y. Gonzalez-Fernandez and Colleagues Advance Knowledge in Osteosarcomas (Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells)
35. New Findings from Korea Institute of Radiological and Medical Sciences in the Area of Osteosarcomas Reported (Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma)
36. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European osteosarcoma intergroup
37. Metastatic osteosarcoma: results of two consecutive therapeutic trials at St. Jude Children's Research Hospital
38. A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis
39. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
40. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II
41. All-trans retinoic acid and interferon-alpha in the treatment of a patient with resistant metastatic osteosarcoma: a case report
42. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomysarcoma
43. Universidad de Las Americas Researchers Provide New Data on Osteosarcomas (A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing) (A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents ...)
44. Inappropriate antidiuretic syndrome hypersecretion after a single dose of cisplatin
45. Cellectar's CLR 131 Receives FDA Orphan Drug Designation for the Treatment of Pediatric Osteosarcoma
46. Data on Cystic Fibrosis Detailed by Researchers at Department of Respiratory and Sleep Medicine (Osteogenic Sarcoma In an Adolescent With Cystic Fibrosis: Successful Treatment Despite Significant Obstacles)
47. Samarium/Gemcitabine Improves Effectiveness of Radiotherapy in Osteosarcoma Patients
48. Data on Osteosarcomas Described by Researchers at Abant Izzet Baysal University (Anticancer drugs with chemotherapeutic interactions with thymoquinone in osteosarcoma cells)
49. Advaxis to Present Survival Data of Lm-LLO Cancer Immunotherapies in Recurrent Cervical Cancer and Canine Osteosarcoma at the Society for Immunotherapy of Cancer 29th Annual Meeting
50. Advaxis's HER2 Immunotherapy Candidate Receives Orphan Drug Designation for Treatment of Osteosarcoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.